Attached files

file filename
10-K - 10-K - Cardiovascular Systems Inccsii10-kx63015.htm
EX-31.2 - EXHIBIT 31.2 - Cardiovascular Systems Incex312-63015.htm
EX-32.1 - EXHIBIT 32.1 - Cardiovascular Systems Incex321-63015.htm
EX-23.1 - EXHIBIT 23.1 - Cardiovascular Systems Incex231-63015.htm
EX-31.1 - EXHIBIT 31.1 - Cardiovascular Systems Incex311-63015.htm
EX-10.10 - EXHIBIT 10.10 - Cardiovascular Systems Incex1010-fy16basesalaries.htm
EX-10.12 - EXHIBIT 10.12 - Cardiovascular Systems Incex1012-fy16directorcomp.htm
EX-10.11 - EXHIBIT 10.11 - Cardiovascular Systems Incex1011-fy16execincentivepl.htm
EX-10.59 - EXHIBIT 10.59 - Cardiovascular Systems Incex1059-2014equityincentive.htm



Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Annual Report on Form 10-K for the year ended June 30, 2015 (the “Report”) by Cardiovascular Systems, Inc. (“Registrant”), I, Laurence L. Betterley, the Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

    
Dated: August 27, 2015
By: /s/ Laurence L. Betterley     
Laurence L. Betterley
Chief Financial Officer